Human T cell leukemia/lymphoma (T-lymphotropic) virus type I (HTLV-I) infection has been considered to be closely associated with the leukemogenesis of adult T cell leukemia (ATL), in which interleukin 2 (IL-2) receptors are abnormally expressed. In this study, however, Southern blot analysis revealed no gross rearrangement or obvious amplification of the IL-2 receptor gene in ATL leukemic cells, indicating that abnormal IL-2 receptor expression in ATL is not due to the structural change of its gene. Hence, we studied the expression of the IL-2 receptor and HTLV-I at the RNA level during short-term cultures of leukemic cells from 9 ATL patients. Cytoplasmic dot hybridization and Northern hybridization revealed that fresh leukemic cells from seven of nine patients expressed a small amount of IL-2 receptor mRNA but HTLV-I RNA was undetectable in all cases. After cultures for up to 7 d, both IL-2 receptor mRNA and HTLV-I RNA (including pX message) expression concomitantly increased, whereas the amounts of other cellular genes, except for jB-actin, did not.
Introduction
Human T cell leukemia/lymphoma virus type I (human Tlymphotropic retrovirus type I; HTLV-I)' was first discovered in a T cell line derived from an American patient with an xanthine-guanine phosphoribosyl transferase; HTLV-I, human T cell leukemia/lymphoma virus type I; LTR, long terminal repeat; STLV, simian T cell leukemia virus; TPA, 12-O-tetradecanoylphorbol- I 3-acetate. aggressive type of cutaneous T cell lymphoma (1) . Identification of the same type of virus (2, 3) independently found and isolated (4, 5) from a cell line derived from a Japanese adult T cell leukemia (ATL) patient (6) , and subsequent serological (7-9) and virological (10) studies indicate that HTLV-I infection is closely associated with the leukemogenesis of ATL. Recent studies (1 1, 12) demonstrating the transcriptional transactivation of the HTLV-I long terminal repeat (LTR) by pX region product(s) suggest that it plays a role in viral replication and possibly in transformation of T cells by transactivation of the cellular gene(s), which is directly or indirectly involved in the cell growth.
The proliferation of the peripheral mature T cells initiated by the stimulation of T cell receptor/T3 complex is controlled mainly by the regulation of the production of interleukin 2 (IL-2) and the expression of its receptor (13, 14) . Since the demonstration ofTac antigen (IL-2 receptor) on leukemic cells from ATL patients (15) , we have reported the spontaneous and continuous ("constitutive") expression and some abnormal features of IL-2 receptors in ATL (16) (17) (18) , and proposed the hypothesis that abnormally expressed IL-2 receptors induced by HTLV-I infection play a key role in the leukemogenesis of ATL.
The association of HTLV-I infection and IL-2 receptor expression has been suggested from the following observations: peripheral blood leukemic cells from ATL patients express IL-2 receptors (15, 18) ; HTLV-I-infected cell line cells express an enhanced number of IL-2 receptors (19) ; HTLV-I-infected rat T cell lines and STLV (an analogous virus of HTLV-I in a monkey)-infected cell lines express IL-2 receptors of each species (20, 21) . However, fresh peripheral blood leukemic cells do not express HTLV-I viral antigen (22) or RNA (23) in most cases. In addition, analyses of the HTLV-I proviral integration site and the rearrangement of T cell receptor 3-chain gene demonstrated that most cell lines cultured from ATL patients are not the same clone as the leukemic cell clone (24) (25) (26) . In this context, it is important to study the relation of HTLV-I and IL-2 receptor expression in leukemic cells from ATL patients but not cell lines.
In this paper we first performed Southern blot analysis of the IL-2 receptor gene of leukemic cells from ATL patients to see whether constitutive IL-2 receptor expression in ATL is due to its structural changes. As no such abnormalities were found, we next studied simultaneously both HTLV-I and IL-2 receptor expression at the RNA level, taking the advantage of the enhancement of cell surface IL-2 receptor expression in short-term cultured leukemic cells. And we will show the concomitant enhancement of HTLV-I viral RNA and IL-2 recep-Methods Patients and diagnosis. Nine patients with ATL were studied (Table I) . Their ages ranged from 25 to 78 yr, and five of them were male. The diagnosis of ATL was made by clinical features (6) , morphological characteristics (6), cell surface phenotypes ofleukemic cells (15) , serum antibodies to ATL-associated antigens (ATLA) (4) , and the HTLV-I proviral integration (10) in DNA of leukemic cells. Peripheral white blood cell count ranged from 35,000 to 249,000/mm3.
Cell separation and culture. Peripheral blood mononuclear cells were separated from heparinized blood by Ficoll-Conray density gradient centrifugation. Leukemic cells were cultured in RPMI 1640 medium (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 10% FCS (Gibco, Grand Island, NY), and 20 jsg/ml gentamicin or tobramycin for 3-8 d. Normal peripheral blood mononuclear cells without cultivation and those cultured with 0.1% phytohemagglutinin-P (PHA-P) (Difco Laboratories, Detroit, MI) or with 0.1% PHA-P and 10 ng/ml 12-O-tetradecanoylphorbol-I3-acetate (TPA) (Sigma Chemical Co., St. Louis, MO) for 20 h were used as controls. HTLV-I-infected Hut 102 and MT-I (kindly provided by Dr. I. Miyoshi, Kochi Medical School, Kochi, Japan) cell lines and HTLV-I-uninfected HPB-ALL and HL-60 cell lines were maintained in RPMI 1640 medium containing 10% FCS. To examine the effect of cycloheximide, leukemic cells were cultured with 10 jug/ml cycloheximide (Sigma Chemical Co.).
Flow cytometric detection of IL-2 receptors. IL-2 receptors expressed on leukemic cells before and after cultures for 2 d were detected by flow cytometric analysis after indirect immunofluorescence staining with anti-Tac monoclonal antibody (27, 28) as described previously (18) .
Radiolabeled anti-Tac antibody binding assay. Radiolabeled antiTac antibody binding assay was performed as described previously (18) to measure the total number of IL-2 receptors.
Cytoplasmic dot hybridization. Cytoplasmic dot hybridization was performed according to the method described by White et al. (29) . In brief, 5 (Fig. 2 A) , fresh leukemic cells expressed a small amount of IL-2 receptor mRNA, which was about 1/24 that of Hut 102 cells. When the cytoplasmic extracts obtained after the cultivation of the leukemic cells were examined, the expression of IL-2 receptor mRNA increased gradually, reached a peak on the fourth day, and then slightly decreased on the seventh day. The maximal amount of IL-2 receptor mRNA expressed was twice that of Hut 102 cells. In case Y.S. (Fig. 3 A) , fresh cells scarcely expressed IL-2 receptor mRNA, but after culture for 1 d a large quantity of IL-2 receptor mRNA was expressed. The maximal expression was comparable to that of Hut 102 cells. In contrast, fresh leukemic cells from patient Y.T. (Fig. 4 A) mRNA expression in the remaining ATL cases examined were similar to these three representative cases.
The characteristics of the IL-2 receptor mRNA expression in the nine ATL cases were: In fresh leukemic cells, the expression of IL-2 receptor mRNA was detectable in seven of nine patients and it varied from virtually no expression to 1/24 that of Hut 102 cells. After short-term cultures, the amount of IL-2 receptor mRNA per cell increased although the degree and the rate of its increase varied.
In cytoplasmic dot hybridization studies, the quantity of IL-2 receptor mRNA per cell was measured. In addition, the contents of IL-2 receptor mRNA per total cellular RNA were examined by Northern blot analysis (Fig. 5 A) . Two species of IL-2 receptor mRNA, 3.5 and 1.5 kb, were detected as reported previously (35, 41 (Fig. 4 B) , leukemic cells expressed slight viral RNA even after cultivation. The pattern of the increase of HTLV-I viral RNA expression was similar to that of IL-2 receptor mRNA expression in every case we examined. In Northern blot analysis three major species of RNA (8.5, 4.2, and 2.1 kb) were detected (Fig. 5 B) , which represent When 10 ug/ml of cycloheximide was added at the beginning of the culture, such increases in IL-2 receptor mRNA and HTLV-I viral RNA expression as seen in the culture without cycloheximide were not observed (Figs. 6 A and B) . In contrast, the amount of T cell receptor U-chain mRNA rather increased by the addition of cycloheximide (Fig. 6 C) . However, such an inhibitory effect of cycloheximide on the IL-2 receptor mRNA and HTLV-I viral RNA expression was no longer observed when it was added 24 h after the initiation of the culture (Figs. 6 A and B) .
Expression of other cellular genes in fresh and cultured leukemic cells. We also studied the expression of other cellular different sizes, 1.3 and 1.0 kb, as reported previously (26) . In contrast, about 23-and 2 to 22-fold increases of T cell receptor (-chain mRNA were noted after l-d culture in cases Y.S. and Y.T., respectively (Figs. 3 Cand 4 C). However, the increase of IL-2 receptor mRNA was more than 25-fold in these two cases and Northern blot analysis showed no increase of T cell receptor (-chain mRNA in case Y.S. (Fig. 5 C) . Furthermore, leukemic cells from case Y.T. expressed relatively abundant T cell receptor (3-chain mRNA though the expression of IL-2 receptor mRNA and viral RNA was slight.
Effect of cycloheximide on the expression ofIL-2 receptor mRNA, viral RNA, and T cell receptor (-chain mRNA. We examined the effects of cycloheximide, a protein synthesis in- (Fig.  7 C) . Furthermore, the addition of cycloheximide at the beginning of or 12 h after the cultures inhibited the increase of fl-actin mRNA as well as IL-2 receptor mRNA and viral RNA.
In contrast, the addition of cycloheximide at 24 h of cultures inhibited the increase of (-actin mRNA but not IL-2 receptor mRNA or viral RNA (Fig. 7 D) . The expression of IL-2 mRNA (Fig. 8 A) and HPRT mRNA (data not shown) was hardly detectable throughout short-term cultures in every case. The expression of c-myc mRNA (Fig. 8 B) was also hardly detectable in every case except for two cases. In one case (case M.S.) the expression of c-myc mRNA was maximal on the fourth and fifth day of culture when the expression of IL-2 receptor mRNA and viral RNA was also maximal (Fig. 8 B, left) . In leukemic cells and then decreased (data not shown). When the amount ofrRNA was assessed as an indicator ofthe amount of total RNA applied to each dot, no increase of rRNA comparable to that of IL-2 receptor mRNA or viral RNA was observed during cultures (Fig. 8 C) .
Discussion
As increasing evidence has demonstrated high homology or structural similarities between some oncogene products and cell growth factors or their receptors (43) (44) (45) (46) , the studies focusing on the involvement of cell growth factors or their receptors in the oncogenesis have become increasingly important for clarifying the mechanism of the oncogenesis. However, the number of papers reporting the abnormal expression of cell growth factor receptors in the human neoplastic cells is so far limited. The overexpression of the surface epidermal growth factor receptor was reported in primary human squamous cell carcinomas and primary human brain tumors of glial origin, as well as human squamous carcinoma cell lines. Such overexpression in human squamous carcinoma cell lines and human glial tumors was considered to be the result ofgene amplification (47) (48) (49) (50) (51) . In the previous reports (15) (16) (17) (18) findings are similar to the absence of expression of bovine leukemia virus, a member of the HTLV family, in cells of fully developed bovine tumors (53) . In contrast, IL-2 receptor expression was detected in fresh leukemic cells from most patients at both IL-2 receptor protein and mRNA levels although the expression was weak or mild. Once the leukemic cells were isolated from patients and cultured for a short period, both HTLV-I RNA and IL-2 receptor mRNA expression concurrently increased. As shown in case Y.T. in which HTLV-I viral RNA and IL-2 receptor mRNA expression was low in both fresh and cultured cells, and in cases M.S. and Y.S. where both HTLV-I viral RNA and IL-2 receptor mRNA were strongly expressed, the degrees of their expression were well correlated with each other in every case. In addition, the expression of both IL-2 receptor mRNA and HTLV-I viral RNA concomitantly increased in leukemic cells cultured for up to 7 d and the patterns of their cytoplasmic dot hybridization studies were quite similar in each case.
Demonstration of IL-2 receptor expression in leukemic cells from ATL patients (15, 18) , HTLV-I-infected human cell lines (19) , rat T cell lines (20) and STLV-infected cell lines (21) strongly suggested a close association between HTLV-I infection and IL-2 receptor expression. However, studies to clarify their association and its mechanism in leukemic cells from 58 Umadome, Uchiyama, Hori, Tamori, Motoi, Araki, and Uchino which cytoplasmic extracts were derived and the manner of sample dilutions are as described in Fig. 2 However, another explanation is that the increase of f-actin mRNA is secondary to the activation of the viral and the IL-2 receptor genes by pX product. It may be reflected in the fact that the addition of cycloheximide 24 h after the initiation of the culture inhibited the increase of f-actin mRNA but not those of IL-2 receptor and viral RNA. In any case, we can not exclude the possibility that pX product activates several cellular genes, one of which is the IL-2 receptor gene.
Although we studied a limited number of cases, there The patients whose leukemic cells weakly expressed IL-2 receptor mRNA and HTLV-I RNA tend to run a chronic clinical course. The study of much more cases will be required to exactly determine the correlation between the clinical parameters and HTLV-I and/or IL-2 receptor expression.
From our results and those reported by others, it seems likely that IHJTLV-I infection induces constitutive IL-2 receptor expression in not only cell line cells but also leukemic cells from ATL patients. To clarify the role ofabnormally expressed IL-2 receptors in 'the leukemogenesis of ATL, we need further studies on the mechanism of the induction of IL-2 receptor expression by HTLV-I infection and the function of IL-2 receptor associated with cell growth of HTLV-I infected cells.
